1093 related articles for article (PubMed ID: 19400867)
1. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
Dietrich J; Doherty TM
APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
[TBL] [Abstract][Full Text] [Related]
2. TB vaccine strategies--what is needed to solve a complex problem?
Dietrich J; Lundberg CV; Andersen P
Tuberculosis (Edinb); 2006; 86(3-4):163-8. PubMed ID: 16678489
[TBL] [Abstract][Full Text] [Related]
3. Advances in tuberculosis vaccine strategies.
Skeiky YA; Sadoff JC
Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
[TBL] [Abstract][Full Text] [Related]
4. Analyzing the interaction of pathogens with the host immune system.
Jayachandran R; Scherr N; Pieters J
Immunol Lett; 2009 Feb; 122(2):112-4. PubMed ID: 19135088
[TBL] [Abstract][Full Text] [Related]
5. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
Sierra VG
Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
[TBL] [Abstract][Full Text] [Related]
6. Novel tuberculosis vaccines on the horizon.
Parida SK; Kaufmann SH
Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
[TBL] [Abstract][Full Text] [Related]
7. Vaccine approaches to prevent tuberculosis.
Wiker HG; Mustafa T; Målen H; Riise AM
Scand J Immunol; 2006 Sep; 64(3):243-50. PubMed ID: 16918693
[TBL] [Abstract][Full Text] [Related]
8. Antituberculous vaccine development: a perspective for the endemic world.
Verma I; Grover A
Expert Rev Vaccines; 2009 Nov; 8(11):1547-53. PubMed ID: 19863247
[TBL] [Abstract][Full Text] [Related]
9. Host versus pathogen: two sides of the same challenge in the TB world.
Cooper AM
Eur J Immunol; 2009 Mar; 39(3):632-3. PubMed ID: 19283712
[No Abstract] [Full Text] [Related]
10. Development of vaccines against bovine tuberculosis.
Hogarth PJ; Hewinson RG; Vordermeier HM
J Pharm Pharmacol; 2006 Jun; 58(6):749-57. PubMed ID: 16734976
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the global crisis: "yes, we can", but also for TB ... ?
Ottenhoff TH
Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
[TBL] [Abstract][Full Text] [Related]
12. Rational design of vaccines against tuberculosis directed by basic immunology.
Reece ST; Kaufmann SH
Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
[TBL] [Abstract][Full Text] [Related]
13. New tuberculosis vaccines.
Martín Montañés C; Gicquel B
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
[TBL] [Abstract][Full Text] [Related]
14. Future vaccination strategies against tuberculosis: thinking outside the box.
Kaufmann SH
Immunity; 2010 Oct; 33(4):567-77. PubMed ID: 21029966
[TBL] [Abstract][Full Text] [Related]
15. The second Geneva Consensus: Recommendations for novel live TB vaccines.
Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH
Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686
[TBL] [Abstract][Full Text] [Related]
16. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
17. [Strategies for the development of new tuberculosis vaccines].
Fattorini L
Minerva Med; 2007 Apr; 98(2):109-19. PubMed ID: 17519853
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis vaccine research: the impact of immunology.
Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
[TBL] [Abstract][Full Text] [Related]
19. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis.
Silva BD; da Silva EB; do Nascimento IP; Dos Reis MC; Kipnis A; Junqueira-Kipnis AP
Vaccine; 2009 Jul; 27(33):4402-7. PubMed ID: 19500525
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis: vaccines in the pipeline.
Ly LH; McMurray DN
Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]